Stephen J. Hemsley returned as UnitedHealth Group CEO in May 2025. The company reshuffled nearly 50% of its top 100 executive roles through late 2025 and 2026. Key appointments include a new CFO and a new CEO for the Optum division. [1, 2, 10]
Management is responding to investor scrutiny and a margin squeeze in the Medicare Advantage business. Rising medical costs and flat government reimbursement rates drive these financial pressures. [7, 8]
New leadership is tightening financial controls and repricing insurance plans to improve profitability. The company is exiting less profitable markets to protect margins. [2, 9]